𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost Effectiveness of Enoxaparin in Acute ST-Segment Elevation Myocardial Infarction: The ExTRACT–TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment–Thrombolysis In Myocardial Infarction 25) Study

✍ Scribed by Leo Marcoff; Zugui Zhang; Wei Zhang; Edward Ewen; Claudine Jurkovitz; Prisca Leguet; Paul Kolm; William S. Weintraub

Book ID
119268466
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
813 KB
Volume
54
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of enoxaparin compare
Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: A Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment – Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial
✍ Robert C. Welsh; Luc Sauriol; Zugui Zhang; Paul Kolm; William S. Weintraub; Pier 📂 Article 📅 2009 🏛 Pulsus Group Inc 🌐 English ⚖ 709 KB
Enoxaparin versus unfractionated heparin
Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction: Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)
✍ Elliott M. Antman; David A. Morrow; Carolyn H. McCabe; Frank Jiang; Harvey D. Wh 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 631 KB